USD 3.3 billion
Report ID:
SQMIG15E2398 |
Region:
Global |
Published Date: March, 2024
Pages:
184
|Tables:
64
|Figures:
75
Global Point-of-Care glucose testing Market size was valued at USD 3.3 billion in 2022 and is poised to grow from USD 3.44 billion in 2023 to USD 4.78 billion by 2031, at a CAGR of 4.2% during the forecast period (2024-2031).
The global point-of-care glucose testing market is a rapidly growing sector in the healthcare industry. It involves the use of portable glucose testing devices that provide immediate results, enabling healthcare professionals and individuals to monitor blood glucose levels conveniently at the point of care. The market is driven by the increasing prevalence of diabetes and the need for regular glucose monitoring to manage the disease effectively. Point-of-care glucose testing offers several advantages, including quick results, improved patient outcomes, and reduced healthcare costs. The primary purpose of the point-of-care glucose testing market is to facilitate timely and accurate glucose monitoring, particularly for individuals with diabetes. It allows for immediate measurement of blood glucose levels, enabling healthcare professionals to make informed decisions regarding treatment plans and adjustments to medication dosages.
Point-of-care testing also empowers individuals to take control of their health by providing them with real-time information to manage their glucose levels more effectively. By promoting early detection, monitoring, and intervention, the market aims to improve patient outcomes and enhance overall diabetes management. One of the key driving factors in the global point-of-care glucose testing market is the rising prevalence of diabetes worldwide. The increasing incidence of diabetes, coupled with the growing awareness of the importance of regular glucose monitoring, drives the demand for point-of-care testing devices. Despite the market's growth potential, there are certain restraining factors that need to be considered. One such factor is the cost associated with point-of-care glucose testing devices, which may limit their affordability for some individuals and healthcare facilities. The global point-of-care glucose testing market faces several challenges. One of the significant challenges is ensuring the accuracy and precision of glucose testing devices. Calibration issues, interferences from various substances, and user errors can affect the reliability of test results. Standardization and quality control measures need to be implemented to address these challenges. The point-of-care glucose testing market presents significant opportunities for growth and innovation.
The development of advanced biosensor technologies, including non-invasive glucose monitoring, holds immense potential for the market. Integration with digital health platforms, electronic health records, and telehealth services can further enhance the market's opportunities. The global point-of-care glucose testing market serves the purpose of providing convenient and immediate glucose monitoring for individuals with diabetes. The market is driven by the increasing prevalence of diabetes, advancements in technology, and the need for better disease management. While there are challenges to overcome, such as ensuring accuracy and addressing cost concerns, there are also opportunities for innovation, expansion into emerging markets, and integration with digital health platforms. The market's ultimate goal is to empower individuals, improve patient outcomes, and enhance the management of diabetes on a global scale.
US Point-of-care Glucose Testing Market is poised to grow at a sustainable CAGR for the next forecast year.
Global Market Size
USD 3.3 billion
Largest Segment
OTC Testing
Fastest Growth
Prescription-based Testing
Growth Rate
4.2% CAGR
To get more reports on the above market click here to Buy The Report
The global point-of-care glucose testing market is segmented on the prescription, end-use, and region. By prescription, the market is segmented into OTC testing, Prescription-based testing. In terms of segmentation by end-use, the market is segmented into hospitals, diagnostic centers, research laboratories, home-care settings, and others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Point-of-care Glucose Testing Market Analysis by Prescription
Prescription-based testing holds the largest share in the global market due to its widespread use in healthcare settings. It involves glucose testing conducted under the guidance and supervision of healthcare professionals. This segment caters to patients with chronic conditions such as diabetes, where regular monitoring of blood glucose levels is crucial for effective disease management. Prescription-based testing offers accurate and reliable results, making it the preferred choice for healthcare providers in managing patient care. The growing prevalence of diabetes and the increasing adoption of point-of-care glucose testing devices in hospitals, clinics, and diagnostic centers contribute to the dominance of the prescription-based testing segment.
OTC testing is the fastest-growing segment in the global point-of-care glucose testing market. OTC testing refers to glucose testing performed by individuals themselves without a prescription or medical supervision. The growing trend of self-monitoring and the availability of user-friendly and convenient glucose testing devices have fueled the demand for OTC testing. These devices allow individuals to monitor their blood glucose levels at their convenience, providing real-time information for self-management of conditions like prediabetes or diabetes. The accessibility and ease of use of OTC testing devices have made them popular among individuals seeking greater control over their health and well-being.
Point-of-care Glucose Testing Market Analysis by End-use
Hospitals represent the largest end-use segment in the global market due to their role as primary healthcare providers and the high volume of patients they serve. Glucose testing in hospitals is essential for effective disease management, especially for patients with diabetes or other conditions that require regular monitoring of blood glucose levels. Hospitals have well-established infrastructure, trained healthcare professionals, and access to a wide range of diagnostic devices, including point-of-care glucose testing systems. The demand for glucose testing in hospitals is driven by the need for accurate and timely results, enabling healthcare providers to make informed decisions regarding patient care. The prevalence of chronic diseases, increasing patient inflow, and the focus on providing comprehensive healthcare services contribute to the dominance of hospitals in the market.
Home-care settings represent the fastest-growing segment in the global point-of-care glucose testing market. Home-care settings include individuals' residences, assisted living facilities, and other non-medical environments where patients receive healthcare services. The growth of the home-care segment can be attributed to several factors. Firstly, there is a growing preference for remote monitoring and self-management of chronic conditions, including diabetes. Point-of-care glucose testing devices that are user-friendly, portable, and easy to operate have enabled individuals to monitor their blood glucose levels conveniently in the comfort of their homes. Additionally, the COVID-19 pandemic has accelerated the adoption of home-based healthcare solutions, including point-of-care glucose testing, to minimize hospital visits and ensure patient safety. The convenience, privacy, and cost-effectiveness of home-care settings have driven the demand for glucose testing devices in these environments.
To get detailed analysis on other segments, Request For Free Sample Report
North America holds the largest market share in the global point-of-care glucose testing market. This dominance can be attributed to several factors, including the high prevalence of diabetes in the region, well-established healthcare infrastructure, and favorable reimbursement policies. The presence of key market players, technological advancements, and the adoption of innovative glucose testing devices contribute to the region's leadership position. Additionally, increasing awareness among healthcare professionals and patients about the benefits of point-of-care glucose testing drives market growth in North America.
The Asia Pacific region is experiencing rapid growth in the point-of-care glucose testing market. Factors such as the growing prevalence of diabetes, a large population base, increasing healthcare expenditure, and rising awareness of the importance of glucose monitoring drive market growth in this region. Moreover, the rising disposable income and improving healthcare infrastructure in emerging economies, including China and India, are significant contributors to the market's expansion. The adoption of point-of-care glucose testing devices in home-care settings and the increasing focus on preventive healthcare further fuel market growth in the Asia Pacific region.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Point-of-care Glucose Testing Market Drivers
Rising Diabetes Prevalence
Technological Advancements
Point-of-care Glucose Testing Market Restraints
Cost Constraints
Regulatory Challenges
Request Free Customization of this report to help us to meet your business objectives.
The global point-of-care glucose testing market is a highly competitive landscape with the presence of several key players. These companies strive to maintain their market position by focusing on product innovation, strategic partnerships, and geographical expansion. Key players in the competitive landscape of the global point-of-care glucose testing market continuously strive to introduce advanced technologies, improve product efficacy, and enhance user experience. They also engage in strategic partnerships, mergers, and acquisitions to strengthen their market position and expand their geographical presence. With a focus on innovation and customer-centric approaches, these companies contribute significantly to the growth and development of the point-of-care glucose testing market.
Point-of-care Glucose Testing Market Top Player’s Company Profiles
Point-of-care Glucose Testing Market Recent Developments
In January 2024, Amazon declared its intention to partner with digital health firms to offer virtual care benefits to customers, especially for managing chronic conditions such as diabetes and hypertension. Omada Health, a virtual-first chronic care provider, was revealed as Amazon's inaugural partner in this initiative.
In February 2024, Trinity Biotech (TRIB) finalized a conclusive agreement to purchase the biosensor and Continuous Glucose Monitoring (CGM) assets from Waveform Technologies. This strategic acquisition, valued at $12.5 million in cash and 9 million American Depositary Shares (ADSs) of the company, alongside additional considerations, positions Trinity Biotech to innovate diabetes care and upgrade its presence in the biosensor market.
In July 2023, Avricore Health and Ascensia Diabetes Care revealed a partnership to incorporate blood glucose monitoring into point-of-care testing. The collaboration seeks to integrate the Contour Next-Gen and Contour Next One BGM systems into Avricore’s HealthTab PCOT platform.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our global point-of-care glucose testing market is expected to experience significant growth during the forecast period from 2023 to 2030. The market is witnessing significant growth and is driven by various factors. This market analysis aims to provide a simplified overview of the market dynamics. Point-of-care glucose testing refers to the testing of blood glucose levels at or near the patient's location, providing quick and convenient results. The market is fuelled by the increasing prevalence of diabetes worldwide, leading to a rising demand for glucose testing devices. Factors such as the need for immediate diagnosis, effective disease management, and convenience for patients contribute to the market's growth. However, the market faces challenges such as the high cost of testing devices and regulatory requirements for accuracy and quality control.
Despite these challenges, there are opportunities for market growth, such as the integration of glucose testing devices with digital health platforms and the focus on remote patient monitoring. These trends enable seamless data sharing, real-time monitoring, and improved disease management. Overall, the global point-of-care glucose testing market is dynamic and driven by the growing demand for efficient and convenient glucose monitoring solutions in the healthcare industry.
Report Metric | Details |
---|---|
Market size value in 2023 | USD 3.3 billion |
Market size value in 2031 | USD 4.78 billion |
Growth Rate | 4.2% |
Forecast period | 2024-2031 |
Forecast Unit (Value) | USD Billion |
Segments covered |
|
Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
Companies covered |
|
Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
For the Point-of-care Glucose Testing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Point-of-care Glucose Testing Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Point-of-care Glucose Testing Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Point-of-care Glucose Testing Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG15E2398
sales@skyquestt.com
USA +1 351-333-4748